Weight Loss Drug Mounjaro to Be Launched in India in 2025; Know How It Tackles Obesity
Global pharma giant Eli Lilly plans to launch its diabetes and obesity treatment, tirzepatide, marketed under the brands ...
McKnight's Long-Term Care News1h
FDA approves Zepbound for sleep apnea in patients with obesity
The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).
India Today on MSN2h
Elon Musk's Christmas post ft him dressed as 'Ozempic Santa'
Billionaire Elon Musk has posted a photo of himself on Christmas dressed as Santa Claus and called himself an 'Ozempic Santa' ...
Elon Musk admits to being on Ozempic-like weight loss drug in Santa Claus post on Christmas
Elon Musk admitted to he takes an Ozempic-like weight loss drug in a festive holiday post while wearing a Santa Claus outfit ...
FDA approves first medication for obstructive sleep apnea — which also promotes weight loss
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).
Alaska Dispatch News12hOpinion
Opinion: We’ve accepted Wegovy and Zepbound. The next phase is harder.
An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...
Zepbound Weight Loss Medication Approved by FDA to Treat Sleep Apnea
The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as ...
WQOW20h
FDA approves weight-loss drug Zepbound for obstructive sleep apnea
The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...
The Sacramento Observer21h
What Black Folks Say About Weight Loss Meds and the Holidays
Branneisha Cooper was terrified of attending her first holiday gathering after starting Mounjaro. The 28-year-old ...